Alvotech (ICE:ALVO)
Iceland
· Delayed Price · Currency is ISK 1,585.00
0.00 (0.00%)
At close: Mar 3, 2025
Alvotech Employees
Alvotech had 999 employees as of December 31, 2023. The number of employees increased by 82 or 8.94% compared to the previous year.
Employees
999
Change (1Y)
82
Growth (1Y)
8.94%
Revenue / Employee
53.20M ISK
Profits / Employee
-59.62M ISK
Market Cap
466.17B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marel | 7,500 |
| Íslandsbanki | 764 |
| Arion banki | 822 |
| Sildarvinnslan Hf. | 723 |
| Brim hf. | 694 |
| Hagar | 2,699 |
| Kvika banki | 270 |
| Festi | 1,352 |
Alvotech News
- 7 days ago - Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET - GlobeNewsWire
- 10 days ago - Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara - Reuters
- 10 days ago - Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. - GlobeNewsWire
- 10 days ago - Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. - GlobeNewsWire
- 13 days ago - FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea - Investopedia
- 13 days ago - Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) - GlobeNewsWire
- 13 days ago - Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) - GlobeNewsWire
- 5 weeks ago - Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) - GlobeNewsWire